Share
News

US Vaccination Effort Ramps Up with Another Shot on Deck for Authorization

Share

Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination campaign on Tuesday, with a second vaccine on the cusp of government authorization.

A day after the rollout of Pfizer-BioNTech’s shots, the Food and Drug Administration said its preliminary analysis confirmed the effectiveness and safety of the vaccine developed by Moderna and the National Institutes of Health.

A panel of outside experts is expected to vote to recommend the vaccine on Thursday, with the FDA’s green light coming soon thereafter.

The Moderna vaccine uses the same technology as Pfizer-BioNTech’s and showed similarly strong protection against COVID-19 but is easier to handle because it does not need to be kept at minus 94 degrees Fahrenheit.

Packed in dry ice, shipments of the Pfizer-BioNTech vaccine began arriving Tuesday at more than 400 hospitals and other distribution sites.

Trending:
US Missionaries Slaughtered in Haiti, Ambushed by 3 Truck Loads of Gang Members - Biden Silent So Far

The first 3 million shots are being limited to health workers and nursing home patients.

Maritza Beniquez, a 56-year-old emergency room nurse at Newark’s University Hospital, became the first person in New Jersey to receive the vaccine on Tuesday.

In Manchester, New Hampshire, intensive care unit nurse Heidi Kukla said she volunteered to get the shot first to help dispel fears about the vaccine’s long-term effects and the speed with which it was developed.

Just half of Americans say they want to get vaccinated, while about a quarter don’t and the rest are unsure, according to a recent poll by The Associated Press-NORC Center for Public Health Research.

Are you willing to receive a COVID-19 vaccine?

The federal government is planning hundreds more shipments through the weekend.

Shots for nursing home residents won’t start in most states until next week, when some 1,100 facilities are set to begin vaccinations.

Government officials project that 20 million Americans will be able to get shots by the end of December, and 30 million more in January.

The U.S. government has purchased 100 million doses of the Pfizer-BioNTech vaccine and 200 million doses of Moderna’s.

If everything goes smoothly, that would be enough to vaccinate 150 million Americans by mid-2021. Both vaccines require a second dose a few weeks after an initial shot.

Related:
Red Lobster Files for Bankruptcy, Announces 'Stalking Horse' Sale

Elsewhere around the world, the Pfizer-BioNTech vaccine is being given in Britain and Canada. And European Union regulators moved up a meeting to assess the vaccine to Dec. 21, more than a week earlier than planned, under pressure from Germany and other countries on the continent.

In scrutinizing early results of a 30,000-person study, the FDA found that Moderna’s vaccine worked just about as well as Pfizer-BioNTech’s.

The Moderna vaccine was more than 94 percent effective overall at preventing COVID-19, and 86 percent effective in people 65 and older.

The FDA uncovered no major safety problems. Side effects can include fever, fatigue and aches.

Even such a large study can’t detect very rare problems. Britain last week reported some possible reactions among people with a history of severe allergies who received the Pfizer-BioNTech shot.

The FDA found no serious allergic reactions in the Moderna study. About 1.5 percent of vaccine recipients reported possible small, “hypersensitivity” reactions.


[jwplayer pN7MDRXv]

The Western Journal has reviewed this Associated Press story and may have altered it prior to publication to ensure that it meets our editorial standards.

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , , , , ,
Share
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands. Photo credit: @AP on Twitter
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
Location
New York City




Conversation